CI
BSX icon

Corient IA’s Boston Scientific BSX Stock Holding History

Corient IA’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$355K Sell
5,650
-1,350
-19% -$108K 0.33% 111
2025
Q4 		$667K Hold
7,000
– – 0.63% 36
2025
Q3 		$683K Hold
7,000
– – 0.51% 52
2025
Q2 		$752K Hold
7,000
– – 0.44% 64
2025
Q1 		$706K Buy
+7,000
New +$705K 0.5% 45

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Corient IA's BSX Position: Q1 2026 in Review

Corient IA reduced its Boston Scientific (BSX) stake by 19% in Q1 2026, selling an estimated $108K and leaving 5,650 shares worth $355K. The position accounts for 0.33% of the portfolio, ranked #111.

Corient IA first reported a position in BSX in Q1 2025 and has held it in 5 quarters since. The position peaked at $752K in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Corient IA held 5,650 shares of Boston Scientific worth $355K as of Q1 2026.
  • Corient IA sold 1,350 Boston Scientific shares in Q1 2026, an estimated $108K.
  • Boston Scientific made up 0.33% of Corient IA's portfolio in Q1 2026, its #111 holding.
  • Corient IA first reported a position in Boston Scientific in Q1 2025 and has held it in 5 quarters since.
  • Corient IA's Boston Scientific position peaked at $752K in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Corient IA's 13F filing for Q1 2026, filed 14 May 2026.